{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:46:17Z","timestamp":1782344777845,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005089","name":"Beijing Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["7212142"],"award-info":[{"award-number":["7212142"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102435"],"award-info":[{"award-number":["82102435"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.biopha.2024.116558","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:01:15Z","timestamp":1712707275000},"page":"116558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Indirubin-3\u2032-monoxime exhibits potent antiviral and anti-inflammatory effects against human adenoviruses in vitro and in vivo"],"prefix":"10.1016","volume":"174","author":[{"given":"Junyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaojie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaofu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinying","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xidong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjie","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enlu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyang","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.116558_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105034","article-title":"Emerging antiviral therapeutics for human adenovirus infection: recent developments and novel strategies","volume":"188","author":"Dodge","year":"2021","journal-title":"Antivir. Res."},{"key":"10.1016\/j.biopha.2024.116558_bib2","first-page":"86","article-title":"Respiratory viruses in transplant recipients: more than just a cold. Clinical syndromes and infection prevention principles","volume":"62","author":"Abbas","year":"2017","journal-title":"Int. J. Infect. Dis.: IJID: Off. Publ. Int. Soc. Infect. Dis."},{"key":"10.1016\/j.biopha.2024.116558_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1128\/CMR.00116-13","article-title":"Adenovirus infections in immunocompetent and immunocompromised patients","volume":"27","author":"Lion","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.biopha.2024.116558_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/microbiolspec.DMIH2-0020-2015","article-title":"Adenovirus","volume":"4","author":"Ison","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.biopha.2024.116558_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2018.03.001","article-title":"USC-087 protects Syrian hamsters against lethal challenge with human species C adenoviruses","volume":"153","author":"Toth","year":"2018","journal-title":"Antivir. Res"},{"key":"10.1016\/j.biopha.2024.116558_bib6","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3201\/eid2206.151898","article-title":"Human Adenovirus Associated with Severe Respiratory Infection, Oregon, USA, 2013-2014","volume":"22","author":"Scott","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.biopha.2024.116558_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1378\/chest.13-1186","article-title":"Emergence of community-acquired adenovirus type 55 as a cause of community-onset pneumonia","volume":"145","author":"Cao","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.biopha.2024.116558_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines6010030","article-title":"The Repertoire of Adenovirus in Human Disease: The Innocuous to the Deadly","volume":"6","author":"Khanal","year":"2018","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2024.116558_bib9","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1055\/s-0036-1584923","article-title":"Adenovirus: epidemiology, global spread of novel serotypes, and advances in treatment and prevention","volume":"37","author":"Lynch","year":"2016","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.biopha.2024.116558_bib10","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.drudis.2015.07.007","article-title":"Antiadenovirus drug discovery: potential targets and evaluation methodologies","volume":"20","author":"Mart\u00ednez-Aguado","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2024.116558_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2024.116558_bib12","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2174\/1568026616666160930131737","article-title":"Repurposing of anticancer drugs for the treatment of bacterial infections","volume":"17","author":"Soo","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116558_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113112","article-title":"Pharmacological properties of indirubin and its derivatives","volume":"151","author":"Yang","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2024.116558_bib14","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1054\/bjoc.2000.1546","article-title":"Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells","volume":"84","author":"Marko","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2024.116558_bib15","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3892\/etm.2017.4701","article-title":"Effects of indigo naturalis on colonic mucosal injuries and inflammation in rats with dextran sodium sulphate-induced ulcerative colitis","volume":"14","author":"Wang","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.biopha.2024.116558_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115522","article-title":"Psoriasis treatment using Indigo Naturalis: Progress and strategy","volume":"297","author":"Zhang","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2024.116558_bib17","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1365-2141.2005.05655.x","article-title":"Indirubin, a Chinese anti-leukaemia drug, promotes neutrophilic differentiation of human myelocytic leukaemia HL-60 cells","volume":"130","author":"Suzuki","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.biopha.2024.116558_bib18","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/j.bmcl.2015.03.066","article-title":"Discovery of novel indirubin-3\u2032-monoxime derivatives as potent inhibitors against CDK2 and CDK9","volume":"25","author":"Yan","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2024.116558_bib19","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1097\/01.aids.0000194805.74293.11","article-title":"Indirubin-3\u2032-monoxime, a derivative of a Chinese antileukemia medicine, inhibits P-TEFb function and HIV-1 replication","volume":"19","author":"Heredia","year":"2005","journal-title":"AIDS (Lond., Engl. )"},{"key":"10.1016\/j.biopha.2024.116558_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.antiviral.2014.03.019","article-title":"Anti-inflammatory and antiviral effects of indirubin derivatives in influenza A (H5N1) virus infected primary human peripheral blood-derived macrophages and alveolar epithelial cells","volume":"106","author":"Mok","year":"2014","journal-title":"Antivir. Res"},{"key":"10.1016\/j.biopha.2024.116558_bib21","first-page":"11961","article-title":"Inhibition of hepatitis B virus in HepG2.2.15 by indirubin through suppression of a polypyrimidine tract-binding protein","volume":"10","author":"Ying Yang","year":"2017","journal-title":"Int J. Clin. Exp. Med"},{"key":"10.1016\/j.biopha.2024.116558_bib22","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1073\/pnas.0800200105","article-title":"Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model","volume":"105","author":"Toth","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2024.116558_bib23","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/femsre\/fuz008","article-title":"Drug development against human adenoviruses and its advancement by Syrian hamster models","volume":"43","author":"Wold","year":"2019","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.biopha.2024.116558_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2003.08.003","article-title":"The cotton rat model for adenovirus ocular infection: antiviral activity of cidofovir","volume":"61","author":"Kaneko","year":"2004","journal-title":"Antivir. Res"},{"key":"10.1016\/j.biopha.2024.116558_bib25","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/22221751.2021.1895679","article-title":"Chinese tree shrew: a permissive model for in vitro and in vivo replication of human adenovirus species B","volume":"10","author":"Li","year":"2021","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.biopha.2024.116558_bib26","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tips.2012.04.005","article-title":"Adenovirus receptors: implications for targeting of viral vectors","volume":"33","author":"Arnberg","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2024.116558_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.prrv.2005.09.005","article-title":"Transgenic mice","volume":"7","author":"Hickman-Davis","year":"2006","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.biopha.2024.116558_bib28","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.1128\/JVI.00205-12","article-title":"A new human DSG2-transgenic mouse model for studying the tropism and pathology of human adenoviruses","volume":"86","author":"Wang","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2024.116558_bib29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1365-2443.1996.d01-244.x","article-title":"A membrane cofactor protein transgenic mouse model for the study of discordant xenograft rejection","volume":"1","author":"Yannoutsos","year":"1996","journal-title":"Genes Cells.: Devoted Mol. Cell. Mech."},{"key":"10.1016\/j.biopha.2024.116558_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29026","article-title":"A novel humanized tri-receptor transgenic mouse model of HAdV infection and pathogenesis","volume":"95","author":"Wang","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.biopha.2024.116558_bib31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.antiviral.2018.09.015","article-title":"A standardized approach to the evaluation of antivirals against DNA viruses: Orthopox-, adeno-, and herpesviruses","volume":"159","author":"Hartline","year":"2018","journal-title":"Antivir. Res"},{"key":"10.1016\/j.biopha.2024.116558_bib32","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0166-3542(02)00077-3","article-title":"Antiherpes simplex virus type 2 activity of casuarinin from the bark of Terminalia arjuna Linn","volume":"55","author":"Cheng","year":"2002","journal-title":"Antivir. Res"},{"key":"10.1016\/j.biopha.2024.116558_bib33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.virol.2003.11.028","article-title":"Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in vitro and in vivo","volume":"320","author":"Rivera","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.biopha.2024.116558_bib34","article-title":"Differential Expression of ABC Transporter Genes in Brain Vessels vs. Peripheral Tissues and Vessels from Human, Mouse and Rat","volume":"15","author":"Zhang","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2024.116558_bib35","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1128\/AAC.04348-14","article-title":"Pharmacokinetics and safety of intravenous cidofovir for life-threatening viral infections in pediatric hematopoietic stem cell transplant recipients","volume":"59","author":"Caruso Brown","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2024.116558_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01925-18","article-title":"Cidofovir diphosphate inhibits adenovirus 5 DNA polymerase via both nonobligate chain termination and direct inhibition, and polymerase mutations confer cidofovir resistance on intact virus","volume":"63","author":"Chamberlain","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2024.116558_bib37","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1128\/AAC.05983-11","article-title":"First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA viruses","volume":"56","author":"Painter","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2024.116558_bib38","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.bbmt.2016.12.621","article-title":"Brincidofovir for asymptomatic adenovirus viremia in pediatric and adult allogeneic hematopoietic cell transplant recipients: a randomized placebo-controlled phase II trial","volume":"23","author":"Grimley","year":"2017","journal-title":"Biol. Blood Marrow Transplant.: J. Am. Soc. Blood Marrow Transplant."},{"key":"10.1016\/j.biopha.2024.116558_bib39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc2602","article-title":"Cell cycle, CDKs and cancer: a changing paradigm","volume":"9","author":"Malumbres","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2024.116558_bib40","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1172\/JCI73805","article-title":"CDK9 inhibitor FIT-039 prevents replication of multiple DNA viruses","volume":"124","author":"Yamamoto","year":"2014","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.biopha.2024.116558_bib41","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1101\/gad.1318105","article-title":"A structural perspective of CTD function","volume":"19","author":"Meinhart","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.biopha.2024.116558_bib42","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0092-8674(00)80939-3","article-title":"A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA","volume":"92","author":"Wei","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2024.116558_bib43","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1128\/JVI.03046-12","article-title":"Adenovirus L-E1A activates transcription through mediator complex-dependent recruitment of the super elongation complex","volume":"87","author":"Vijayalingam","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2024.116558_bib44","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1073\/pnas.76.8.3665","article-title":"An adenovirus type 5 early gene function regulates expression of other early viral genes","volume":"76","author":"Jones","year":"1979","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2024.116558_bib45","first-page":"187","article-title":"Adenovirus DNA replication: protein priming, jumping back and the role of the DNA binding protein DBP","volume":"272","author":"de Jong","year":"2003","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.biopha.2024.116558_bib46","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1128\/JVI.77.2.915-922.2003","article-title":"Adenovirus type 5 DNA binding protein stimulates binding of DNA polymerase to the replication origin","volume":"77","author":"van Breukelen","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2024.116558_bib47","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.tranon.2019.08.010","article-title":"Indirubin 3\u2032-oxime inhibits migration, invasion, and metastasis InVivo in mice bearing spontaneously occurring pancreatic cancer via blocking the RAF\/ERK, AKT, and SAPK\/JNK pathways","volume":"12","author":"Ichimaru","year":"2019","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.biopha.2024.116558_bib48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/08830185.2013.823420","article-title":"Adenoviruses types, cell receptors and local innate cytokines in adenovirus infection","volume":"33","author":"Chen","year":"2014","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.biopha.2024.116558_bib49","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1471-2334-14-147","article-title":"Cross-sectional study of the relationship of peripheral blood cell profiles with severity of infection by adenovirus type 55","volume":"14","author":"Chen","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.biopha.2024.116558_bib50","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.21037\/jtd-19-4067","article-title":"Comparison of clinical characteristics and inflammatory cytokines between hypoxemic and non-hypoxemic human adenovirus 55 pneumonia","volume":"12","author":"Lim","year":"2020","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.biopha.2024.116558_bib51","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00011-011-0413-7","article-title":"Indirubin-3-monoxime exhibits anti-inflammatory properties by down-regulating NF-\u03baB and JNK signaling pathways in lipopolysaccharide-treated RAW264.7 cells","volume":"61","author":"Kim","year":"2012","journal-title":"Inflamm. Res"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224004426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224004426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T22:48:43Z","timestamp":1782341323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224004426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":51,"alternative-id":["S0753332224004426"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116558","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indirubin-3\u2032-monoxime exhibits potent antiviral and anti-inflammatory effects against human adenoviruses in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116558","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116558"}}